North American Scientific to Present at NYSSA Medical Conference on June 12
06 Giugno 2007 - 10:00PM
Business Wire
North American Scientific, Inc. (Nasdaq:NASI) announced today that
it will present at The New York Society of Security Analysts
(NYSSA) 2007 Medical Equipment & Supplies Industry Conference
on Tuesday, June 12, 2007 at NYSSA�s headquarters on 1177 Avenue of
the Americas in New York. President and CEO John Rush, who joined
North American Scientific in April 2007, will present the Company�s
business strategies and market opportunities at 10:00 a.m. Eastern
Time. North American Scientific will offer a live audio webcast of
its presentation, which may be accessed through the Company�s
website at www.nasmedical.com. An archived replay will also be
available on the Company�s website shortly after the live
presentation, and will be available for one year. About North
American Scientific North American Scientific is a leader in
radiation therapy products and services in the fight against
cancer. Its innovative products provide physicians with tools for
the treatment of various types of cancers. They include Prospera�
brachytherapy seeds and SurTRAK� needles and strands used primarily
in the treatment of prostate cancer. In addition the Company plans
to commercialize its ClearPath� multi-channel catheter breast
brachytherapy devices in 2007, which are the only devices approved
for both high dose and continuous release, or low dose, radiation
treatments. The devices are designed to provide flexible, precise
dose conformance and an innovative delivery system that is intended
to offer the more advanced form of brachytherapy for the treatment
of breast cancer. North American Scientific�s NOMOS� Radiation
Oncology Division provides external beam radiation therapy products
for Serial Tomotherapy Intensity Modulated Radiation Therapy (IMRT)
and Image-Guided Radiation Therapy (IGRT). Serial tomotherapy IMRT
allows an escalated radiation dose to be delivered to a tumor while
limiting exposure and damage to nearby healthy tissue. These
products are marketed under the trade names nomosSTAT�and CORVUS�
(our proprietary treatment planning software). The Company's IGRT
products, BAT�, BATCAM� and nTRAK�, provide fast and accurate
targeting and localization of a treatment volume on a daily basis.
More than 500 hospitals and research sites worldwide are equipped
with the Company's clinically proven serial tomotherapy, inverse
treatment planning, image-guidance and ancillary treatment
solutions. Please visit www.nasmedical.com for more information.
Grafico Azioni North American Scientific (MM) (NASDAQ:NASI)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni North American Scientific (MM) (NASDAQ:NASI)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a North American Scientific (MM) (NASDAQ): 0 articoli recenti
Più North American Scientific, Inc. Articoli Notizie